Glyxambi

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0597-0164
  • Package NDC 0597-0164-30
  • Package NDC 0597-0164-39
  • Package NDC 0597-0164-90
  • Application number NDA206073
  • SPL ID 16f275d5-7526-4e7a-8776-665a9a6ae37a
  • SPL set ID ddbab689-f76c-488c-9613-4168d41dd730
  • UNII 3X29ZEJ4R2
  • UNII HDC1R2M35U
  • RxCUI 1602109
  • RxCUI 1602115
  • RxCUI 1602118
  • RxCUI 1602120

What the source publishes

Labeler
Boehringer Ingelheim Pharmaceuticals, Inc.
Active ingredients
empagliflozin and linagliptin
Form
TABLET, FILM COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0597-0164_16f275d5-7526-4e7a-8776-665a9a6ae37a
{
  "name": "Glyxambi",
  "splId": "16f275d5-7526-4e7a-8776-665a9a6ae37a",
  "labels": [
    {
      "setId": "ddbab689-f76c-488c-9613-4168d41dd730",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ddbab689-f76c-488c-9613-4168d41dd730",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ddbab689-f76c-488c-9613-4168d41dd730"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Boehringer Ingelheim Pharmaceuticals, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET, FILM COATED in 1 BOTTLE (0597-0164-30)",
      "package_ndc": "0597-0164-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20150130"
    },
    {
      "sample": false,
      "description": "30 BLISTER PACK in 1 CARTON (0597-0164-39)  / 1 TABLET, FILM COATED in 1 BLISTER PACK",
      "package_ndc": "0597-0164-39",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20150130"
    },
    {
      "sample": false,
      "description": "90 TABLET, FILM COATED in 1 BOTTLE (0597-0164-90)",
      "package_ndc": "0597-0164-90",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20150130"
    }
  ],
  "productId": "0597-0164_16f275d5-7526-4e7a-8776-665a9a6ae37a",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED",
  "productNdc": "0597-0164",
  "deaSchedule": null,
  "genericName": "empagliflozin and linagliptin",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "EMPAGLIFLOZIN",
      "strength": "25 mg/1"
    },
    {
      "name": "LINAGLIPTIN",
      "strength": "5 mg/1"
    }
  ],
  "applicationNumber": "NDA206073",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20150130",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175912",
      "N0000175913",
      "N0000187059",
      "N0000187058"
    ],
    "unii": [
      "3X29ZEJ4R2",
      "HDC1R2M35U"
    ],
    "rxcui": [
      "1602109",
      "1602115",
      "1602118",
      "1602120"
    ],
    "spl_set_id": [
      "ddbab689-f76c-488c-9613-4168d41dd730"
    ],
    "pharm_class_epc": [
      "Dipeptidyl Peptidase 4 Inhibitor [EPC]",
      "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Dipeptidyl Peptidase 4 Inhibitors [MoA]",
      "Sodium-Glucose Transporter 2 Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Boehringer Ingelheim Pharmaceuticals, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0597-0164_16f275d5-7526-4e7a-8776-665a9a6ae37a"